Literature DB >> 23963159

Arrhythmia risk in long QT syndrome: beyond the disease-causative mutation.

John R Giudicessi, Michael J Ackerman.   

Abstract

Entities:  

Keywords:  Editorials; genetics; ion channels; long QT syndrome

Mesh：

Substances：

Year:  2013        PMID： 23963159      PMCID： PMC3848876          DOI： 10.1161/CIRCGENETICS.113.000260

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN： 1942-3268


× No keyword cloud information.
  19 in total

1.  KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.

Authors:  Lia Crotti; Andrew L Lundquist; Roberto Insolia; Matteo Pedrazzini; Chiara Ferrandi; Gaetano M De Ferrari; Alessandro Vicentini; Ping Yang; Dan M Roden; Alfred L George; Peter J Schwartz
Journal:  Circulation       Date:  2005-08-22       Impact factor: 29.690

2.  Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.

Authors:  David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2005-05       Impact factor: 6.343

3.  A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels.

Authors:  Jonathan C Makielski; Bin Ye; Carmen R Valdivia; Matthew D Pagel; Jielin Pu; David J Tester; Michael J Ackerman
Journal:  Circ Res       Date:  2003-09-18       Impact factor: 17.367

4.  QT interval prolongation predicts cardiovascular mortality in an apparently healthy population.

Authors:  E G Schouten; J M Dekker; P Meppelink; F J Kok; J P Vandenbroucke; J Pool
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

5.  Low penetrance in the long-QT syndrome: clinical impact.

Authors:  S G Priori; C Napolitano; P J Schwartz
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

6.  A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation.

Authors:  Prakash C Viswanathan; D Woodrow Benson; Jeffrey R Balser
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

7.  The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome.

Authors:  G M Vincent; K W Timothy; M Leppert; M Keating
Journal:  N Engl J Med       Date:  1992-09-17       Impact factor: 91.245

8.  Common variants at ten loci modulate the QT interval duration in the QTSCD Study.

Authors:  Arne Pfeufer; Serena Sanna; Dan E Arking; Martina Müller; Vesela Gateva; Christian Fuchsberger; Georg B Ehret; Marco Orrú; Cristian Pattaro; Anna Köttgen; Siegfried Perz; Gianluca Usala; Maja Barbalic; Man Li; Benno Pütz; Angelo Scuteri; Ronald J Prineas; Moritz F Sinner; Christian Gieger; Samer S Najjar; W H Linda Kao; Thomas W Mühleisen; Mariano Dei; Christine Happle; Stefan Möhlenkamp; Laura Crisponi; Raimund Erbel; Karl-Heinz Jöckel; Silvia Naitza; Gerhard Steinbeck; Fabio Marroni; Andrew A Hicks; Edward Lakatta; Bertram Müller-Myhsok; Peter P Pramstaller; H-Erich Wichmann; David Schlessinger; Eric Boerwinkle; Thomas Meitinger; Manuela Uda; Josef Coresh; Stefan Kääb; Gonçalo R Abecasis; Aravinda Chakravarti
Journal:  Nat Genet       Date:  2009-03-22       Impact factor: 38.330

9.  Common variants at ten loci influence QT interval duration in the QTGEN Study.

Authors:  Christopher Newton-Cheh; Mark Eijgelsheim; Kenneth M Rice; Paul I W de Bakker; Xiaoyan Yin; Karol Estrada; Joshua C Bis; Kristin Marciante; Fernando Rivadeneira; Peter A Noseworthy; Nona Sotoodehnia; Nicholas L Smith; Jerome I Rotter; Jan A Kors; Jacqueline C M Witteman; Albert Hofman; Susan R Heckbert; Christopher J O'Donnell; André G Uitterlinden; Bruce M Psaty; Thomas Lumley; Martin G Larson; Bruno H Ch Stricker
Journal:  Nat Genet       Date:  2009-03-22       Impact factor: 38.330

10.  Risk stratification in the long-QT syndrome.

Authors:  Silvia G Priori; Peter J Schwartz; Carlo Napolitano; Raffaella Bloise; Elena Ronchetti; Massimiliano Grillo; Alessandro Vicentini; Carla Spazzolini; Janni Nastoli; Georgia Bottelli; Roberta Folli; Donata Cappelletti
Journal:  N Engl J Med       Date:  2003-05-08       Impact factor: 91.245
View more
  6 in total

1.  Aggregate penetrance of genomic variants for actionable disorders in European and African Americans.

Authors:  Pradeep Natarajan; Nina B Gold; Alexander G Bick; Heather McLaughlin; Peter Kraft; Heidi L Rehm; Gina M Peloso; James G Wilson; Adolfo Correa; Jonathan G Seidman; Christine E Seidman; Sekar Kathiresan; Robert C Green
Journal:  Sci Transl Med       Date:  2016-11-09       Impact factor: 17.956

2.  Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.

Authors:  Tianbo Jin; Xugang Shi; Li Wang; Huijuan Wang; Tian Feng; Longli Kang
Journal:  BMC Genet       Date:  2016-05-28       Impact factor: 2.797

Review 3.  Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.

Authors:  E Giacomelli; C L Mummery; M Bellin
Journal:  Cell Mol Life Sci       Date:  2017-06-01       Impact factor: 9.261

4.  Modification of distinct ion channels differentially modulates Ca2+ dynamics in primary cultured rat ventricular cardiomyocytes.

Authors:  Xichun Li; Liping Shen; Fang Zhao; Xiaohan Zou; Yuwei He; Fan Zhang; Chunlei Zhang; Boyang Yu; Zhengyu Cao
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

Review 5.  Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling.

Authors:  Daniel R Bayzigitov; Sergey P Medvedev; Elena V Dementyeva; Sevda A Bayramova; Evgeny A Pokushalov; Alexander M Karaskov; Suren M Zakian
Journal:  Cardiol Res Pract       Date:  2016-03-27       Impact factor: 1.866

6.  Jervell and Lange-Nielsen syndrome with novel KCNQ1 and additional gene mutations.

Authors:  Shinichi Matsuda; Yuko Ohnuki; Mayuri Okami; Eriko Ochiai; Shiro Yamada; Kazumi Takahashi; Motoki Osawa; Kenji Okami; Masahiro Iida; Hiroyuki Mochizuki
Journal:  Hum Genome Var       Date:  2020-10-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.